Yakira Capital Management’s Epizyme, Inc EPZM Stock Holding History

Yakira Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-174,500	Closed	-$257K	–	495
2022 Q2	$257K	Buy	+174,500	New	+$128K	0.04%	230

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Yakira Capital Management's EPZM Position: Q3 2022 in Review

Yakira Capital Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 174,500 shares — an estimated $257K sold.

Yakira Capital Management first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $257K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Yakira Capital Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Yakira Capital Management sold 174,500 Epizyme, Inc shares in Q3 2022, an estimated $257K.
Yakira Capital Management first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
Yakira Capital Management's Epizyme, Inc position peaked at $257K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Yakira Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.